Skip to main content

Table 3 Round 1 descriptive statistics

From: Clinical indicators to identify neuropathic pain in low back related leg pain: a modified Delphi study

Round 1 criteria for consensus:
Median value of participants Likert scale data ≥ 3
Percentage of agreement 50% (Wiangkham et al., 2016 [25])
Clinical indicator Median Percentage of agreement Consensus achieved
Pain variously described as burning, shooting, sharp, aching or electric-shock-like 4 85.7% Y
History of nerve injury, pathology or mechanical compromise 4 77.2% Y
Pain in association with other neurological symptoms (e.g. pins and needles, numbness, weakness) 4 77.2% Y
Pain referred in a dermatomal or cutaneous distribution 3 48% N
Less responsive to simple analgesia/NSAIDS and/or more responsive to anti-epileptic (e.g. Neurontin, Lyrica)/anti-depression (e.g. Amitriptyline) medication 3 39% N
Pain of high severity and irritability (i.e. easily provoked, taking longer to settle) 4 54.3% Y
Mechanical pattern to aggravating and easing factors involving activities/postures associated with movements, loading or compression of neural tissue 3 42.9% N
Pain in association with other dysesthesias (e.g. crawling, electrical, heaviness) 4 68.6% Y
Reports of spontaneous pain (i.e. stimulus independent) and/or paroxysmal pain (i.e. sudden recurrences and intensification of pain) 4 51.4% Y
Pain/symptom provocation with mechanical/movement tests (e.g. Active/Passive, Neurodynamic, i.e. SLR, Brachial plexus tension test) that move/load/compress neural tissue 4 65.7% Y
Pain/symptom provocation on palpation of relevant neural tissues 4 51.4% Y
Positive neurological signs (including altered reflexes, sensation and muscle power in dermatomal/myotomal or cutaneous nerve distribution) 4 63.8% Y
Antalgic posturing of the affected limb/body part 2 37.1% N
Positive findings of hyperalgesia (primary or secondary) and/or allodynia and/or hyperpathia within the distribution of pain 4 57.2% Y